SOPH Stock SOPHiA GENETICS SA (SOPH, $4.05) price exceeded its 50-day Moving Average on November 17, 2025

GET DAILY SIGNALS

Get AI intraday signals

SOPH - SOPHiA GENETICS SA

Moving Avg. signal

View

Odds of DOWN Trend

Price: $4.05

Daily change: -$0.26 (-6.03%)

Daily volume: 76K

Capitalization: $274.8M

Industry: Services to the Health Industry

This price move could indicate a change in the trend, and may be a sell signal for investors. A.I.dvisor found 50 similar cases, and were successful. Based on this data, the odds of success are

SOPH's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for SOPH moved out of overbought territory on October 31, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SOPH as a result. In of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SOPH turned negative on November 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

SOPH moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOPH broke above its upper Bollinger Band on October 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where SOPH advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.482) is normal, around the industry mean (22.568). P/E Ratio (0.000) is within average values for comparable stocks, (102.886). SOPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.404). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (3.674) is also within normal values, averaging (65.399).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.